Stock Market News

BioNTech stock falls after FDA clinical hold on malaria vaccine trial

Mar 4, 2025 - 22:49
 0
BioNTech stock falls after FDA clinical hold on malaria vaccine trial
Read More

Tags:

Previous Article

BlackRock to buy Hong Kong firm's Panama Canal port stake amid Trump pressure

Next Article

TD Bank CEO Raymond Chun's 2024 compensation set at $7.9 million

Related Posts

Amgen India opens with $200 million investment plan through 2025

Amgen India opens with $200 million investment plan thr...

Feb 24, 2025  0

Akamai downgraded by BofA, Piper Sandler on multi-year ...

Feb 21, 2025  0

Mixed analyst calls on Floor & Decor amid housing marke...

Feb 14, 2025  0